Todd A. Fehniger mostly deals with Immunology, Interleukin 21, Natural killer cell, Interleukin 12 and Lymphokine-activated killer cell. His work in Interleukin 15, NK Cell Lectin-Like Receptor Subfamily C, Leukemia, Immune system and Cytokine are all subfields of Immunology research. His Interleukin 21 research incorporates themes from Perforin, Granzyme, Granzyme B and Cell biology.
His research links Innate immune system with Natural killer cell. His Interleukin 12 research is multidisciplinary, relying on both Tumor necrosis factor alpha and Monokine. His Lymphokine-activated killer cell research includes themes of NK-92 and Natural killer T cell.
His primary scientific interests are in Immunology, Internal medicine, Interleukin 21, Interleukin 12 and Cell biology. His research investigates the connection between Immunology and topics such as Natural killer cell that intersect with problems in Haematopoiesis. His Internal medicine research incorporates elements of Gastroenterology, Surgery and Oncology.
His research integrates issues of Granzyme, Granzyme B, Molecular biology and Cellular differentiation in his study of Interleukin 21. His Interleukin 12 study combines topics from a wide range of disciplines, such as Receptor, Adoptive cell transfer and IL-2 receptor. His Cell biology research integrates issues from Cell and microRNA.
His primary areas of investigation include Cancer research, Cell, Immunology, Cell biology and Cytotoxic T cell. Todd A. Fehniger has researched Immunology in several fields, including Natural killer cell and Transplantation. The Natural killer cell study combines topics in areas such as Cancer immunotherapy and Atopic dermatitis.
The concepts of his Cell biology study are interwoven with issues in Myeloid and Cytokine. Todd A. Fehniger combines subjects such as Interleukin 12 and microRNA with his study of Cytokine. His studies deal with areas such as Innate immune system, Innate lymphoid cell and Major histocompatibility complex as well as Cytotoxic T cell.
Cell biology, Leukemia, Cytotoxic T cell, Immunology and Myeloid leukemia are his primary areas of study. His study in Cell biology is interdisciplinary in nature, drawing from both CD16, Cell and Innate immune system, Innate lymphoid cell. His Leukemia research is multidisciplinary, incorporating elements of Hematopoietic stem cell transplantation, Cancer research, Adoptive cell transfer, Interleukin 12 and In vivo.
His research investigates the link between Hematopoietic stem cell transplantation and topics such as Interleukin 18 that cross with problems in Interleukin 15. The concepts of his Cytotoxic T cell study are interwoven with issues in Myeloid, CD34, Induced pluripotent stem cell and Progenitor cell. Human leukocyte antigen, Allergic inflammation, Atopic dermatitis, Cancer immunotherapy and Immune system are the subjects of his Immunology studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The biology of human natural killer-cell subsets.
Megan A Cooper;Todd A Fehniger;Michael A Caligiuri.
Trends in Immunology (2001)
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen.
Interleukin 15: biology and relevance to human disease
Todd A. Fehniger;Michael A. Caligiuri.
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
Xuefang Cao;Sheng F. Cai;Todd A. Fehniger;Jiling Song.
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell–derived IL-2: a potential new link between adaptive and innate immunity
Todd A Fehniger;Megan A Cooper;Gerard J Nuovo;Marina Cella.
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis.
European Journal of Immunology (2017)
Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response
Todd A. Fehniger;Manisha H. Shah;Matthew J. Turner;Jeffrey B. VanDeusen.
Journal of Immunology (1999)
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.
Sherif S. Farag;Todd A. Fehniger;Todd A. Fehniger;Loredana Ruggeri;Loredana Ruggeri;Andrea Velardi;Andrea Velardi.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S. Welch;Allegra A. Petti;Christopher A. Miller;Catrina C. Fronick.
The New England Journal of Medicine (2016)
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs.
European Journal of Immunology (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: